文章摘要
贺楠楠.养血逐寒方对风湿寒性关节痛疗效及血液流变学、中医症状影响探究[J].实用中西医结合临床,2023,23(7):
养血逐寒方对风湿寒性关节痛疗效及血液流变学、中医症状影响探究
Study on the effect of Yangxue Zhuhan Prescription on wind-dampness-cold arthralgia and the influence of hemorheology and TCM symptoms
投稿时间:2023-02-09  修订日期:2023-03-10
DOI:
中文关键词: 风湿寒性关节痛  养血逐寒方  疗效  中医证候积分  血液流变学指标  不良反应
英文关键词: Rheumatic and cold joint pain  Nourishing blood and removing cold  Curative effect  TCM syndrome integral  Hemorheology index  Adverse reactions
基金项目:
作者单位E-mail
贺楠楠* 河南科技大学第一附属医院 cyxsg545@163.com 
摘要点击次数: 322
全文下载次数: 116
中文摘要:
      【摘要】目的 观察养血逐寒方对风湿寒性关节痛的疗效及血液流变学指标、中医症状的影响。方法 研究纳入风湿寒性关节痛患者(2019年5月~2021年11月收治)合计102例进行分组研究,分组方法为随机数字表法,平均分为对照组与观察组,各51例,对照组患者口服塞来昔布治疗,观察组患者口服塞来昔布同时结合养血逐寒方治疗,数据观察:疗效、治疗前后患者血液流变学指标(红细胞比容及红细胞刚性指数、全血低切还原黏度)变化、中医证候(关节疼痛及屈伸不利、肌肉酸麻疼痛或肿胀、口淡不欲饮等)积分变化、疼痛量表(视觉模拟疼评分,VAS)评分、膝关节功能(LKSS)评分、生活质量(GQOLI-74)评分变化及不良反应。结果 观察组患者治疗总有效率为96.08%(49/51),对照组治疗总有效率为84.31%(43/51),观察组患者更高,p<0.05;治疗前,两组患者中医证候(关节疼痛及屈伸不利、肌肉酸麻疼痛或肿胀、口淡不欲饮等)、血液流变学指标(红细胞比容及红细胞刚性指数、全血低切还原黏度)、VAS评分及LKSS评分、GQOLI-74评分比较,p>0.05,治疗后两组患者中医证候(关节疼痛及屈伸不利、肌肉酸麻疼痛或肿胀、口淡不欲饮等)、血液流变学指标(红细胞比容及红细胞刚性指数、全血低切还原黏度)、VAS评分及LKSS评分、GQOLI-74评分等指标优于对照组,观察组患者治疗后中医证候(关节疼痛及屈伸不利、肌肉酸麻疼痛或肿胀、口淡不欲饮等)、血液流变学指标(红细胞比容及红细胞刚性指数、全血低切还原黏度)、VAS评分及LKSS评分、GQOLI-74评分优于对照组,p<0.05;观察组:1例恶心,1例嗜睡;对照组:1例恶心,1例头痛;两组不良反应发生率均较低,p>0.05。结论 养血逐寒方可显著提升风湿寒性关节痛患者临床疗效,患者恢复较好,副反应少,安全可靠。
英文摘要:
      【Abstract】Objective To observe the effect of nourishing blood and removing cold prescription on wind-dampness-cold arthralgia and the influence of hemorheology indexes and TCM symptoms.Methods Research into the wind raw arthralgia patients (may, 2021 to November 2019) total 102 cases of group study, grouping method for the random number table method, average divided into control group and observation group, the 51 cases, control group patients with oral celecoxib treatment, observation group of patients with oral celecoxib combined with nourishing blood by cold treatment, at the same time data observation: Curative effect, changes of hemorheological indexes (RBC specific volume and RBC rigidity index, whole blood hypocut reduction viscosity), changes of TCM syndromes (joint pain and adverse flexion and extension, muscle pain and numbness, pain or swelling, weak mouth and no desire to drink, etc.), changes of pain scale (visual simulated pain score, VAS score, knee function (LKSS) score, quality of life (GQOLi-74) score, adverse reactions.Results The total effective rate was 96.08% (49/51) in the observation group and 84.31% (43/51) in the control group, which was higher in the observation group, P < 0.05; Before treatment, the comparison of TCM syndromes (joint pain and adverse flexion and extension, muscle numbness and pain or swelling, weak mouth and no desire to drink, etc.), hemorheological indexes (RBC specific volume and RBC rigidity index, whole blood hypocut reduction viscosity), VAS score, LKSS score and GQOLI-74 score in 2 groups, P > 0.05. After treatment, TCM syndromes (joint pain and adverse flexion and extension, muscle numbness and pain or swelling, weak mouth and no appetite to drink, etc.), hemorheology indexes (RBC specific volume and RBC rigidity index, whole blood hypocut reduction viscosity), VAS score, LKSS score, GQOLi-74 score and other indexes of patients in the two groups were better than the control group. After treatment, TCM syndromes (joint pain and adverse flexion and extension, muscle numbness and pain or swelling, weak mouth and no appetite to drink, etc.), hemorheology indexes (RBC specific volume and RBC rigidity index, whole blood reduced viscosity), VAS score, LKSS score and GQOLI-74 score in observation group were better than those in control group, P < 0.05; Observation group: 1 case nausea, 1 case drowsiness; Control group: 1 case nausea, 1 case headache; The incidence of adverse reactions was low in both groups (P > 0.05).Conclusion Nourishing blood and removing cold can significantly improve the clinical efficacy of patients with wind-dampness-cold arthralgia, with better recovery, fewer side reactions, safe and reliable.
查看全文   查看/发表评论  下载PDF阅读器
关闭
手机扫一扫看
分享按钮